Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (832)	11/23/2001 10:38:08 PM
From: RCMac	Read Replies (1) \| Respond to of 1834

<<10 down, 10 to go. >. 10 + 10, or 10 by 10? MZ, Message 11410643 To:Mike McFarland who wrote (212) From: Richard Harmon Thursday, Sep 30, 1999 3:25 PM An A for effort I think Yup...... A plus. Thank you for the diligent effort, it has kept many of well-informed. Mike.... these are companies that could do a 50-100X. Of course, one should only use a very small percentage of net worth for any given risky issue, and one should also make a basket with many little eggs....... BTRN NBIX RGEN (if they actually have a patent stance for CTLA4-Ig) As you know, the odds of going to zero are probably better than the odds of 100X.